Xtant Medical Holdings, Inc. (XTNT)
Market Cap | 44.97M |
Revenue (ttm) | 55.98M |
Net Income (ttm) | -8.01M |
Shares Out | 87.31M |
EPS (ttm) | -0.09 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 26,079 |
Open | 0.535 |
Previous Close | 0.520 |
Day's Range | 0.510 - 0.537 |
52-Week Range | 0.450 - 1.360 |
Beta | 1.03 |
Analysts | Sell |
Price Target | n/a |
Earnings Date | Aug 4, 2022 |
About XTNT
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler a... [Read more...]
Financial Performance
In 2021, XTNT's revenue was $55.26 million, an increase of 3.61% compared to the previous year's $53.34 million. Losses were -$4.85 million, -30.96% less than in 2020.
Financial StatementsAnalyst Forecast
No stock price forecast available yet.
News
Xtant Medical Announces Second Quarter 2022 Financial Results
BELGRADE, Mont., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022
BELGRADE, Mont., July 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces First Quarter 2022 Financial Results
BELGRADE, Mont., May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Appoints Scott Neils as Chief Financial Officer
BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022
BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...
Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022
BELGRADE, Mont., March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...
Xtant Medical Announces Fourth Quarter and Full Year 2021 Financial Results
BELGRADE, Mont., March 08, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...
Xtant Medical to Issue Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022
BELGRADE, Mont., March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...
Xtant Medical Appoints Scott Neils Interim Chief Financial Officer
BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces Third Quarter 2021 Financial Results
BELGRADE, Mont., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical to Issue Third Quarter 2021 Financial Results on November 12, 2021
BELGRADE, Mont., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces Second Quarter 2021 Financial Results
BELGRADE, Mont., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical to Present at the Canaccord Musculoskeletal Conference
BELGRADE, Mont., May 13, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Announces First Quarter 2021 Financial Results
BELGRADE, Mont., May 11, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Files $150 Million Shelf Registration Statement
BELGRADE, Mont., May 11, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Announces $20 Million Debt Financing with MidCap Financial
BELGRADE, Mont., May 06, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical to Issue First Quarter 2021 Financial Results on May 11, 2021
BELGRADE, Mont., May 04, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Comments on Trading Activity of its Stock
BELGRADE, Mont., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT, the “Company”), a global medical technology company focused on surgical solutions for the treatment ...
XTNT Stock: 7 Things to Know About Xtant Medical as Shares Rocket 150%
Xtant Medical (XTNT) stock is surging higher Friday and InvestorPlace has everything potential investors need to know about the company. The post XTNT Stock: 7 Things to Know About Xtant Medical as Shar...
Xtant Medical Announces Fourth Quarter and Full Year 2020 Financial Results
BELGRADE, Mont., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces $20 Million Private Placement
BELGRADE, Mont., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT) (the Company), a global medical technology company focused on surgical solutions for the treatment o...
Xtant Medical to Issue Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 24, 2021
BELGRADE, Mont., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces Expiration of Rights Offering
BELGRADE, Mont., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces Third Quarter 2020 Financial Results
BELGRADE, Mont., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces Record Date and Other Key Dates for Proposed $15 Million Rights Offering
BELGRADE, Mont., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...